Financials
Financial year 2025
PHARMACIE GUILMIN - LAMBEAU from Wavre, company number BE0430195691, closed financial year 2025 with a result of € 96,717 after tax. For that financial year PHARMACIE GUILMIN - LAMBEAU recorded a gross margin of € 299,625 and equity of € 504,301. Compared with financial year 2024, the result moved from € 33,446 to € 96,717. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 504,301
▲ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 96,717
▲ 189% vs 2024
Profit after tax over the fiscal year.
€ 62,879
▲ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 442,801.
People and assets in 2025
2.3
Average over the fiscal year, from the social balance sheet.
€ 125,102
▲ 4% vs 2024
€ 54,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 940
▼ 61% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 175,305
▼ 20% vs 2024
€ 45,484 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 52,010
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 58,945
▲ 46% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 202,562 | € 239,441 | € 198,844 | € 299,625 | ▲ 51% |
| Profit after taxes | € 32,933 | € 63,123 | € 33,446 | € 96,717 | ▲ 189% |
| Equity | € 377,571 | € 440,694 | € 407,584 | € 504,301 | ▲ 24% |
| Total debts | € 372,273 | € 320,752 | € 446,618 | € 346,166 | ▼ 22% |
| Cash | € 68,255 | € 89,467 | € 47,096 | € 62,879 | ▲ 34% |
| Land & buildings | - | - | € 146,650 | € 135,079 | ▼ 8% |
| Retained profit | € 316,071 | € 379,194 | € 346,084 | € 442,801 | ▲ 28% |
| Dividend | € 18,693 | € 0 | € 66,556 | € 0 | ▼ 100% |
| Bank debt | € 174,708 | € 144,368 | € 218,492 | € 175,305 | ▼ 20% |
| Balance sheet total | € 749,844 | € 761,445 | € 854,202 | € 850,468 | |
| Employees (FTE) | 2.3 | 2.3 | 2.3 | 2.3 |
By gross margin, PHARMACIE GUILMIN - LAMBEAU ranks 4th of 12 companies with main activity “Detailhandel in farmaceutische producten” in Wavre that publish figures (fiscal year 2025).
Key figures of PHARMACIE GUILMIN - LAMBEAU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMACIE GUILMIN - LAMBEAU the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIE GUILMIN - LAMBEAU?
What happened at PHARMACIE GUILMIN - LAMBEAU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 96,717 (▲ 189% vs 2024). filed late Source: NBB ↗
- Christophe Lambeau became a director. NBB
- New establishment in Wavre. KBO
- Start of the company according to the CBE. KBO
In short
From € 32,933 profit in 2022 to € 96,717 profit in 2025.
Paid € 115,237 in corporate taxes since 2022.
Best year ever: 2025, with € 96,717 profit.
On average € 130,300 of value added per employee in 2025.
Management
Behind PHARMACIE GUILMIN - LAMBEAU is Christophe Lambeau. Christophe Lambeau is also behind GUILMIN-LAMBEAU INVEST.
Directors
According to the 2025 annual accounts
since 2023
Establishments
Establishment units
Physical locations of this company
Place Alphonse Bosch 37
1300 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Wavre
Same main activity (Detailhandel in farmaceutische producten), 16 active companies in Wavre, largest first.
€ 172.2 million revenue · 2026
€ 52.2 million revenue · 2025
€ 28.6 million revenue · 2026
€ 9.5 million revenue · 2026
€ 470,194 gross margin · 2025
€ 378,667 gross margin · 2025
Details
- Company number
- 0430.195.691
- VAT number
- BE 0430.195.691
- Registered office
- Place Alphonse Bosch 37, 1300 Wavre
- Names & denominations
- PHARMACIE GUILMIN - LAMBEAU
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 1986
- Peppol
- Active · Active since 25 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers